Dementia experts from UC San Francisco will join their peers from across the globe on the annual Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston from Oct. 24 to 27. Presentations cover breakthroughs in therapies that clear amyloid – a trademark of Alzheimer’s – and a symposium on patients with early Alzheimer’s symptoms who […]